Can Fite Biofarma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Can Fite Biofarma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
H1 | 2024-08-29 | $0 | $-0.40 | 100.0 % |
Q4 | 2024-03-28 | $-0.01 | $-0.26 | 96.2 % |
Q3 | 2023-11-30 | $-0.43 | $-0.44 | 2.27 % |
Q2 | 2023-08-31 | $-0.40 | $-0.42 | 4.76 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
H1 | 2024-08-29 | $316.00K | $150.00K | 110.7 % |
Q4 | 2024-03-28 | $155.00K | $100.00K | 55.0 % |
Q3 | 2023-11-30 | $196.00K | $100.00K | 96.0 % |
Q2 | 2023-08-31 | $196.00K | $100.00K | 9600.0 % |
Can Fite Biofarma (CANF) is scheduled to report earnings on February 3, 2025. The last reported earnings were for reported on August 29, 2024 for H1.
The Actual EPS was $0.00, which beat the estimate of $-0.40.
The Actual Revenue was $316K, which beat the estimate of $150K.
Browse earnings estimates, EPS, and revenue on all stocks.